-+ 0.00%
-+ 0.00%
-+ 0.00%

Lexaria Bioscience Q3 EPS $(0.21) Misses $(0.16) Estimate, Sales $174.000K Beat $91.333K Estimate

Benzinga·07/14/2025 22:32:06
Listen to the news
Lexaria Bioscience (NASDAQ:LEXX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.16) by 33.76 percent. This is a 61.54 percent decrease over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $174.000 thousand which beat the analyst consensus estimate of $91.333 thousand by 90.51 percent. This is a 107.14 percent increase over sales of $84.000 thousand the same period last year.